Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Clinical-stage psychedelics biotech Cybin Inc.
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of psychedelics and traditional pharma for the treatment of major depressive disorder (MDD) are out.
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge
Microdosing Unveiled: Expert’s Take On The Practice’s Ups & Downs
(See Part 1: Exclusive Insights: How Tech Leaders Are Finding Balance Through Microdosing Psychedelics)
Exclusive Insights: How Tech Leaders Are Finding Balance Through Microdosing Psychedelics
Psychedelics are one of the buzziest topics in tech these days.
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
Clinical-stage psychedelics biotech Cybin (NYSE: CYBN) has completed enrollment in its Phase 2 study of novel deuterated psilocybin analog CYB003 for the potential treatment of Major Depressive Disorder (MDD.)
Peru’s Coca Leaf Will Be Used For Research Toward Treating ADHD, Learn The Details
Magdalena Biosciences, Jaguar Health (NASDAQ: JAGX) and Filament Health (OTCQB: FLHLF)
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
The U.S. Patent and Trademark Office (USPTO) has issued a new patent granting IP rights for the novel composition of matter and methods of use on the psilocybin-based molecules series EVM301 to its developer, Enveric Biosciences (NASDAQ: ENVB).
Oregon’s Voter-Approved Drug Decriminalization Law Under Attack, Ballot Proposal Circulating
Two petitions are circulating in Oregon to overturn the 2020 voter-approved Measure 110 that decriminalized the simple possession of drugs.
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland’s Consumption Site & More
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next